
Annexon, Inc. Stock Analysis & AI Score
Annexon, Inc. (ANNX) has an ST Score of 40.6 (C), driven by its Forecast (A+) and held back by its Profitability (F). Analysts rate it Buy with a $10.50 price target (+176.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Annexon, Inc. (ANNX) has an ST Score of 40.6 (C), driven by its Forecast (A+) and held back by its Profitability (F). Analysts rate it Buy with a $10.50 price target (+176.3% upside).
- Strongest
- ForecastA+
- Weakest
- ProfitabilityF
All factor grades
- ForecastA+
- ValuationB
- GrowthB-
- Financial StrengthC-
- MomentumD+
- ProfitabilityF
- Piotroski1/9
Contact
ANNX stock: frequently asked questions
What is ANNX's ST Score?
Annexon, Inc. (ANNX) has an ST Score of 40.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ANNX a buy, hold, or sell?
Analysts rate ANNX a Buy, with a price target of $10.50 (+176.3% vs the current price). Our ST Score grades it C (40.6/100). The ST Score is a data-driven signal, not a recommendation.
What are ANNX's factor grades?
Valuation B, Profitability F, Financial Strength C-, Momentum D+, Growth B-, Forecast A+.
What is ANNX's valuation grade?
Annexon, Inc. (ANNX) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ANNX's growth grade?
Annexon, Inc. (ANNX) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ANNX's profitability grade?
Annexon, Inc. (ANNX) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ANNX's financial strength grade?
Annexon, Inc. (ANNX) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ANNX?
The average analyst price target for Annexon, Inc. (ANNX) is $10.50 from 11 analysts, which is +176.3% versus the recent price of $3.80.
What is ANNX's Piotroski score?
Annexon, Inc. (ANNX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.